RXMD vs SAEYY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RXMD is a Hold and SAEYY is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RXMD’s FA Score shows that 1 FA rating(s) are green whileSAEYY’s FA Score has 0 green FA rating(s).
- RXMD’s FA Score: 1 green, 4 red.
- SAEYY’s FA Score: 0 green, 5 red.
Price Growth
RXMD (@Drugstore Chains) experienced а 0.00% price change this week, while SAEYY (@Drugstore Chains) price change was -1.39% for the same time period.
The average weekly price growth across all stocks in the @Drugstore Chains industry was +1.03%. For the same industry, the average monthly price growth was +3.68%, and the average quarterly price growth was +3.61%.
Reported Earning Dates
RXMD is expected to report earnings on Aug 15, 2023.
Industries' Descriptions
@Drugstore Chains (+1.03% weekly)The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.
| RXMD | SAEYY | RXMD / SAEYY | |
| Capitalization | 19.7M | 2.12B | 1% |
| EBITDA | -8.77M | -20.47M | 43% |
| Gain YTD | -32.803 | 0.322 | -10,188% |
| P/E Ratio | 80.00 | N/A | - |
| Revenue | 10.1M | 1.27B | 1% |
| Total Cash | 2.23M | 216M | 1% |
| Total Debt | 3.01M | 257M | 1% |
RXMD | ||
|---|---|---|
OUTLOOK RATING 1..100 | 46 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 97 | |
PRICE GROWTH RATING 1..100 | 56 | |
P/E GROWTH RATING 1..100 | 18 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BROCX | 18.66 | 0.28 | +1.52% |
| BlackRock Advantage International Inv C | |||
| MLXCX | 28.30 | 0.32 | +1.14% |
| Catalyst Energy Infrastructure C | |||
| FAYZX | 14.44 | 0.13 | +0.91% |
| Fidelity Advisor Multi-Asset Income I | |||
| DTCCX | 16.09 | 0.11 | +0.69% |
| BNY Mellon Sust US Equity C | |||
| EVDIX | 21.23 | 0.07 | +0.33% |
| Camelot Event Driven Institutional | |||
RXMD and
Correlation & Price change
A.I.dvisor tells us that RXMD and PETS have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RXMD and PETS's prices will move in lockstep.
| Ticker / NAME | Correlation To RXMD | 1D Price Change % | ||
|---|---|---|---|---|
| RXMD | 100% | N/A | ||
| PETS - RXMD | 10% Poorly correlated | +35.78% | ||
| HITI - RXMD | 9% Poorly correlated | +2.26% | ||
| WBA - RXMD | 5% Poorly correlated | +0.43% | ||
| SSY - RXMD | 4% Poorly correlated | -8.35% | ||
| SAEYY - RXMD | 4% Poorly correlated | N/A | ||
More | ||||
SAEYY and
Correlation & Price change
A.I.dvisor tells us that SAEYY and RXMD have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SAEYY and RXMD's prices will move in lockstep.
| Ticker / NAME | Correlation To SAEYY | 1D Price Change % | ||
|---|---|---|---|---|
| SAEYY | 100% | N/A | ||
| RXMD - SAEYY | 4% Poorly correlated | N/A | ||
| ZRSEF - SAEYY | 4% Poorly correlated | N/A | ||
| NVACF - SAEYY | 4% Poorly correlated | N/A | ||
| WLCGF - SAEYY | 0% Poorly correlated | N/A | ||
| SGIPF - SAEYY | -0% Poorly correlated | N/A | ||
More | ||||